Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $76.5 million.

  • Pulmonx's Cash & Current Investments fell 2897.6% to $76.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.5 million, marking a year-over-year decrease of 2897.6%. This contributed to the annual value of $101.5 million for FY2024, which is 1333.88% down from last year.
  • Latest data reveals that Pulmonx reported Cash & Current Investments of $76.5 million as of Q3 2025, which was down 2897.6% from $84.2 million recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Cash & Current Investments ranged from a high of $219.1 million in Q1 2021 and a low of $76.5 million during Q3 2025
  • In the last 5 years, Pulmonx's Cash & Current Investments had a median value of $135.2 million in 2023 and averaged $139.5 million.
  • Per our database at Business Quant, Pulmonx's Cash & Current Investments soared by 124885.17% in 2021 and then plummeted by 2897.6% in 2025.
  • Pulmonx's Cash & Current Investments (Quarter) stood at $180.0 million in 2021, then fell by 21.61% to $141.1 million in 2022, then fell by 17.03% to $117.1 million in 2023, then dropped by 13.34% to $101.5 million in 2024, then decreased by 24.57% to $76.5 million in 2025.
  • Its last three reported values are $76.5 million in Q3 2025, $84.2 million for Q2 2025, and $88.7 million during Q1 2025.